These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra. Masuo Y, Wang H, Pélaprat D, Chi ZQ, Rostène W. Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2520-4. PubMed ID: 1332831 [Abstract] [Full Text] [Related]
3. Evidence for the presynaptic localization of opiate binding sites on striatal efferent fibers. Abou-Khalil B, Young AB, Penney JB. Brain Res; 1984 Dec 03; 323(1):21-9. PubMed ID: 6098334 [Abstract] [Full Text] [Related]
4. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways. Van der Kooy D, Weinreich P, Nagy JI. Neuroscience; 1986 Sep 03; 19(1):139-46. PubMed ID: 2431346 [Abstract] [Full Text] [Related]
5. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Beckstead RM. Neuroscience; 1988 Dec 03; 27(3):851-63. PubMed ID: 3150855 [Abstract] [Full Text] [Related]
6. Demonstration of a pallido-nigral projection innervating dopaminergic neurons. Hattori T, Fibiger HC, McGeer PL. J Comp Neurol; 1975 Aug 15; 162(4):487-504. PubMed ID: 50334 [Abstract] [Full Text] [Related]
10. Distribution of the major gamma-aminobutyric acid(A) receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. Schwarzer C, Berresheim U, Pirker S, Wieselthaler A, Fuchs K, Sieghart W, Sperk G. J Comp Neurol; 2001 May 14; 433(4):526-49. PubMed ID: 11304716 [Abstract] [Full Text] [Related]
14. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata. Celada P, Paladini CA, Tepper JM. Neuroscience; 1999 Mar 14; 89(3):813-25. PubMed ID: 10199615 [Abstract] [Full Text] [Related]
16. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P. Dermon CR, Tzagournissakis M, Savaki HE. Neuroscience; 1992 Oct 14; 50(4):795-809. PubMed ID: 1280349 [Abstract] [Full Text] [Related]
17. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area. Bowery B, Rothwell LA, Seabrook GR. Br J Pharmacol; 1994 Jul 14; 112(3):873-80. PubMed ID: 7921615 [Abstract] [Full Text] [Related]
18. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study. Jessell TM, Emson PC, Paxinos G, Cuello AC. Brain Res; 1978 Sep 08; 152(3):487-98. PubMed ID: 356929 [Abstract] [Full Text] [Related]
19. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons. Lantin le Boulch N, Truong-Ngoc NA, Gauchy C, Besson MJ. Brain Res; 1991 Sep 20; 559(2):200-10. PubMed ID: 1794098 [Abstract] [Full Text] [Related]